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Insulin increases sodium reabsorption in diluting segment in
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Department of Nephrology and Hypertension, University Hospital Utrechi, The Netherlands
Insulin increases sodium reabsorption in diluting segment in humans:
Evidence for indirect mediation through hypokalemia. To examine the
mechanism of renal sodium (Na) and potassium (K) retention during
insulin infusion, seven healthy volunteers underwent clearance studies
without (time control) and with insulin infusion (40 mU bolus, followed
by 1 mU/kg/mm for 150 mm). Maximal free water clearance and
fractional lithium clearance (FELl) were used to analyze renal sodium
handling. Insulin decreased Na excretion (from 189 25 to 121 19
mol/min, P < 0.01) and K excretion (from 64 8 to 19 I mol/min,P < 0.01), but did not change in glomerular filtration rate. FEL
increased from 29.8 1.9 to 32.3 1.9% (P < 0.05), minimal urine
osmolality decreased from 59 3 to 46 3 mOsm/kg (P < 0.01), and
the diluting segment reabsorption index increased from 88.0 0.9 to
93.7 0.9%, P <0.01). Insulin also decreased plasma K, from 3.91
0.08 to 3.28 0.08 mmol/liter, P < 0.01. In a third clearance study KCI
was infused simultaneously (3.75 smol/kg/min) to prevent this fall in
plasma K. In this study insulin had no effect on Na and K excretion and
diluting segment reabsorption, but the rise in FELl remained. In a fourth
clearance study NaCI (3.75 mol/kg/min) instead of KCI was infused
together with insulin. This manoever did not prevent the Na and K
retaining effect of insulin, nor any of its effects on renal sodium handling
parameters. These data suggest that Na and K retention during insulin
infusion are largely secondary to hypokalemia, which causes increased
reabsorption in the diluting segment.
In 1953 Miller and Bogdonoff [1] reported that administration
of insulin in humans causes sodium retention. Later studies in
humans have confirmed this effect [2—51. We found recently that
the sodium (and potassium) retaining effect of insulin infusion is
abolished when the associated hypokalemia is prevented by
simultaneous potassium infusion [6]. This suggests that insulin
causes sodium retention in an indirect manner, that is, via
hypokalemia, which is surprising since the sodium retention of
insulin is generally considered a direct renal effect of this
hormone. Indeed, intrarenal insulin infusion decreases sodium
excretion in the ipsilateral kidney [7]. Insulin also decreases
sodium excretion in the isolated perfused kidney [8]. Insulin has
been shown to increase volume reabsorption in microperfused
rat proximal tubules [91, to stimulate NaIH exchange in
cultured rabbit proximal tubule cells [1OJ, and to enhance
Na,K-ATPase activity in cultured toad kidney cells [11].
One can argue, therefore, that our observation that sodium
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and potassium retention by insulin was prevented by simulta-
neous infusion of KCI [6] concerns a nonspecific effect of the
applied chloride load. To further investigate whether the main
sodium retaining mechanism of insulin in vivo indeed concerns
the indirect effect of hypokalemia we formulated two hypothe-
ses. First, if this were true, prevention of hypokalemia by KCI
infusion should not only be able to abolish the sodium retention
of insulin, but also have the opposite effect on tubular sodium
handling. Second, infusion of an equivalent amount of chloride
with another ion, NaCI instead of KCI, should not prevent the
renal effects of insulin. We presently studied these options in
humans, analyzing segmental sodium reabsorption during insu-
lin infusion without and with simultaneous KCI or NaCl infu-
sion.
Methods
Studies were carried out in seven healthy males (age 24 3
years). Informed consent was obtained, and the protocol was
approved by the Hospital Committee for Studies in Humans.
The subjects took a diet containing a fixed amount of sodium
(300 mmol) and potassium (80 to 100 mmol) for eight days, and
clearance studies were performed on days 4, 5, and 8. Within
four months, a fourth clearance study was performed after four
days of the same dietary regimen. The diet was provided by the
metabolic ward, where the subjects payed a daily visit at noon.
Compliance to the diet was assessed by measurement of 24-
hour urine electrolyte excretion throughout the study.
Clearance studies were performed in the metabolic ward,
after an overnight fast. Before each clearance study a single oral
dose of 400 mg lithium carbonate was taken at the prior evening
at 2200 hours. Between 0830 and 0930 hours a 20 mI/kg water
load was ingested, and additional water matching urinary
output was taken throughout the clearance study. The subjects
were supine, and at 0900 hours a constant infusion of inulin
(polyfructosan, Inutest') was started after a priming dose,
through an indwelling canula in a lower arm vein. A vein in the
contralateral arm was canulated for repeated blood sampling.
After a two-hour equilibration period, when urine osmolality
had reached a minimal value, seven 30-minute urine collections
were made (from 1100 to 1430 hours). Blood samples for
clearance measurements were taken halfway through each
collection period. Blood for plasma renin activity and aldoste-
rone concentration was taken during the second and final urine
collection periods. Throughout the clearance study blood pres-
sure was measured at 10 minutes intervals with an automatic
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sphygmomanometer device (Omega, 1000, Invivo Research
Laboratory Inc., Tulsa, Oklahoma, USA).
The first clearance study (day 4) served as a time-control
study. During the second clearance study (day 5) insulin was
infused (40 mU/kg as a bolus, followed by 1 mU/kg/mm
constant infusion) after the second urine collection. Glucose
was infused as follows: a 5% infusion constantly at 8 ml/kg/hr,
and a 10% infusion adjusted individually to maintain euglyce-
mia. During the third clearance study (day 8) the same infusion
regimen was applied as on day 5; however, potassium chloride
was added to the 5% glucose infusion (28 mmol/liter) to obtain
an infusion rate of 3.75 molIkg/min. This infusion rate effec-
tively prevented hypokalemia during insulin infusion in a study
by DeFronzo et al [12]. The fourth clearance study was similar
as the third, except that now NaCl was infused instead of KCI
(equivalent amount).
Plasma glucose was assessed by an instant hemoglucotest
with a reflectance photometer during the clearance studies, and
reassessed later by spectrophotometry. Blood and urine sam-
ples were analyzed for sodium and potassium (flame photome-
try), chloride (Technicon RA-1000 autoanalyzer), lithium (Per-
kin Elmer 3030 Atomic Absorption Spectrophotometer),
osmolality (Advanced Osmometer), and inulin. The latter was
determined photometrically with indolacetic acid after hydro-
lyzation to fructose [13]. Plasma renin activity (fmol Angioten-
sin I/liter/see) and aldosterone (pmol/liter) were measured by
radioimmunoassay.
Calculations and statistical analysis
Clearances and fractional clearances were calculated by
standard formula. Inulin clearance (C11) was taken as marker
for glomerular filtration rate (GFR). Free water clearance
(CH20) was regarded as index of sodium reabsorption in the
diluting segment, defined as the nephron beyond the point of
isotonicity in the thick ascending limb of Henle's loop (14).
CR2O plus chloride clearance (CH2O + C1) was regarded as an
index of solute delivery to the diluting segment. The term
[(CH2O + therefore represents an approximation of
fractional solute delivery to diluting segment, and the term
[CH20/(CH20 + C1)] an approximation of diluting segment
reabsorption. The validity of these terms and possible pitfalls
have been discussed by others [15]. The lithium clearance has
been advanced as an index of volume delivery to the distal
tubules [161, but this method also has its limitations [17].
Therefore, appropriate caution was applied in the interpretation
of these clearance data.
Statistical analysis was performed by one-way analysis of
variance for repeated measures. Statistical significance of dif-
ferences was tested by Student's t-test for paired observations
using Bonferroni's protection. Values are presented as means
standard error.
Results
During the study there were no significant changes in body
weight (73.7 2.4 and 73.7 2.2 kg on days 3 and 7,
respectively) and 24-hour urine sodium excretion (315 10and
295 26 mmol on days 3 and 7). Prior to the final clearance
study body weight was 74.7 2.0 kg, and 24-hour urine sodium
excretion 290 24 mmol.
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Fig. 1. Plasma potassium during time-control study (0), insulin infu-
sion (•), insulin + KCI infusion (Lx), and insulin + NaG! infusion (A).
"Test" denotes the infusion period, Significant differences from time-
control study are indicated by *, P < 0.01.
Tune control study
Changes in plasma potassium, and urinary sodium and potas-
sium excretion are depicted in Figures 1 and 2. There was no
significant change in these variables during the time control
study. For the analysis of the renal sodium handling data we
compared means of the two baseline collection periods with
means of the final two test periods (Tables I and 2). There were
no significant changes, except for a decrease in maximal urine
flow, whereas urine osmolality was maintained at a minimal
level. Plasma renin activity decreased (P < 0.05), whereas
plasma aldosterone, blood pressure and plasma glucose were
not significantly different in baseline and test periods (Table 3).
Insulin infusion study
In comparison to the time control test, insulin infusion clearly
decreased plasma potassium (Fig. 1), and urinary sodium and
potassium output (Fig. 2). Stable low levels were obtained in
the two final collection periods, which therefore were used to
analyze changes in renal sodium handling (Table 1). Insulin had
no effect on GFR, and the fall in sodium and potassium
excretion was associated with a fall in fractional excretion of
these electrolytes. Fractional chloride excretion decreased as
well. In contrast with the time control study, there was a large
decrease in minimal urine osmolality, but no decrease in
maximal urine flow. The distal delivery term [(CH2O + C1)/
C1,1] did not change, but fractional lithium excretion in-
creased. The diluting segment reabsorption increased as well.
No significant change occurred in plasma renin activity, aldo-
sterone and blood pressure (Table 3). Plasma glucose was
clamped effectively between 4 and 6 mmollliter, as is illustrated
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by the baseline and test period values given in Table 3. The
amount of glucose infused averaged 0.75 0.10 g/kg/hr.
Insulin + KCI infusion study
The potassium infusion prevented the decrease in plasma
potassium observed during insulin alone (Fig. 1), and also
prevented the decrease in urinary potassium and sodium excre-
tion (Fig. 2). Potassium infusion also prevented a number of the
changes in renal sodium handling seen during insulin alone:
there was no decrease in minimal urine osmolality, and no
increase in diluting segment reabsorption (Table 2). However,
during this combined insulin + potassium infusion there still
was an increase in fractional lithium excretion, and no fall in
maximal urine flow as was found in the time control study.
Again no significant change occurred in plasma renin activity,
aldosterone, and blood pressure (Table 3). In this experiment
plasma glucose was also clamped effectively between 4 and 6
mmollliter (mean values in baseline and test periods are given in
Table 3). The amount of glucose needed for this purpose (0.77
0.08 g/kglhr) was comparable to that infused during insulin
alone.
Insulin + NaCI infusion study
In this experiment, instead of KC1, an equivalent amount of
NaCI was infused together with insulin and glucose. The
decrease in plasma potassium was comparable to that found
during insulin alone (Fig. 1). Clearly, although the amount of
chloride infused was identical as in the KCI experiment, the
NaCI infusion did not prevent the fall in urinary sodium and
potassium (Fig. 2) and in urinary chloride excretion (Table 2).
The changes in renal sodium handling parameters were also
comparable to those observed during insulin alone: a decrease
in minimal urine osmolality, an increase in diluting segment
reabsorption term and in fractional lithium clearance, and no
change in maximal urine flow. There were no significant
changes in plasma renin activity, aldosterone, and blood pres-
sure (Table 3). Plasma glucose was again successfully kept at
steady values (mean values of baseline and test periods are
given in Table 3). The glucose infusion rate (0.80 0.07 g/kglhr)
did not differ from that in the two other insulin infusion
experiments.
Discussion
In this study we confirmed our previous finding [6] that
sodium and potassium retention by insulin infusion can be
prevented by simultaneous infusion of KCI in an amount
sufficient to prevent hypokalemia. To find out whether this
concerns the non-specific effect of the chloride load, or whether
the potassium ion is crucial, we also repeated this experiment
during infusion of an identical amount of NaCI. Since this
manoever neither prevented the insulin-induced sodium and
potassium retention, nor the insulin-induced changes in renal
sodium handling parameters (see below), it is likely that hy-
pokalemia somehow plays a mediating role in the sodium
retaining effect of insulin. This option was tested also by
studying whether KCI could prevent the effects of insulin on
renal sodium handling.
Insulin had no effect on GFR, but increased sodium reabsorp-
tion. Maximal urine flow and distal delivery term [(CH20 +
C1)/GFRJ did not change. In fact, maximal urine flow remained
elevated compared to the time-control study. These data,
comparable to observations made by others [1, 3], do not
suggest increased sodium reabsorption in the proximal tubules.
This contrasts with some data from animal studies. Insulin has
been shown to increase volume reabsorption in isolated per-
fused rabbit proximal tubules [9], and to stimulate Na/H
exchange and Na-glucose cotransport in proximal tubule brush
border membrane vesicles [18, 19] and cultured proximal tubule
cells [10]. However, these studies do not discuss the quantita-
tive importance of these effects in vivo. In this respect, micro-
puncture studies are relevant. With this technique applied in
dogs, it was found that insulin reduced proximal tubular sodmm
reabsorption [7]. Since fractional sodium excretion in the urine
decreased as well, it was concluded that insulin increased
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Fig. 2. Urinary sodium and potassium excretions during lime-control
study (0), insulin infusion (I), insulin + KC! infusion (Lx), and insulin
+ NaCI infusion (A). "Test" denotes the infusion period. Significant
differences from time-control study are indicated by *, P < 0.01.
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Table 1. Plasma potassium and clearance data during time control and insulin infusion experiments
Time control Insulin
Baseline Test Baseline Test P value
Plasma potassium mmo!/!izer
C111m!/min
Urine flow mI/mm
Urine osmolality mOsm/kg
CH2o/CflUIIfl %
(CH20 + %
CH o/(CH2O + Cc1) %
Sodium excretion moI/min
Potassium excretion j.unol/min
Chloride excretion .unol/min
FE sodium %
FE potassium %
FE lithium %
3.85 0.08 3.88 0.07
115 4 112 3
15.9 1,4 13.9 l.P
61 3 63 3
10.5 0.9 9.4 0.7
12.1 1.0 10.8 0.8
87.4 1.1 87.2 0.6
202 21 206 20
66 10 56 5
117 25 161 17
1.25 0.11 1.33 0.11
14.9 1.8 12.8 1.1
30.4 2.1 28.4 1.7
3.91 0.08
115 5
15.3 1.3
59 3
10.5 0.8
12.0 1.1
88.0 0.9
189 25
64 8
176 27
1.20 0.15
14.2 1.7
29.8 1.9
3.28 008b
119 6
15.1 1.3
46 3'
10.3 0.8
11.1 0.9
93.7 09b
121 19"
19 I"
94 19b
0.72 0.11"
4.8 03b
32.3 l.9a
b
NS
a
b
NS
NS
b
,
b
b
b
b
b
Values are means (± 5EM) of the two baseline periods ("baseline") and the final two test periods ("test"). Significant differences between test
and baseline are indicated in the "test" columns by a P < 0.05, and b p < 0.01. The left hand column denotes significant differences between the
changes during the time control study versus the changes during the insulin infusion study.
Abbreviations are: C, clearance; FE, fractional excretion.
Table 2. Plasma potassium and clearance data during insulin + KCI infusion and insulin + NaCl infusion experiments
Insulin ÷ KCI Insulin + NaCI P value
Baseline Test Baseline Test A B C
Plasma potassium mmo!/!iter 3.81 0.09 3.74 0.06 3.82 0.08 3.32 005b NS b b
C,1ml/min 117 6 122 5 ill 5 114 4 NS NS NS
Urine flow mI/mm 15,8 1.5 16.5 1.5 15.3 1.0 15.2 1.1 a NS a
Urine osmolality mOsm/kg 62 4 58 3 63 3 51 3b NS a a
CH,O/CIflUIIfl %
(CH20 + C,)/C1011 %
CHO/(CH2O + Ce,) %
Soãium excretion pinol/min
Potassium excretion 4itmol/min
Chloride excretion pinol/min
FENa %
FEK %
FELl %
10.5 0.8
12.1 1.1
87.6 1.4
221 30
64 10
193 37
1.38 0.20
13.9 1.9
30.4 1.8
10.8 0.7
12.5 1.0
87.2 1.9
219 32
64 17
191 38
1.32 0.22
14.1 3.1
32.7 l.7a
10.6 0.7
12.1 0.9
88.0 0.7
185 20
64 10
166 19
1.23 0.13
14.8 2.3
33.1 2.0
10.8 0.7
11.7 0.7
93.2 08b
112 17"
20 3'
95 16b
0.71 0.1P
5.2 07b
36.2 1,5b
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
b
b
b
b
a
NS
NS
NS
b
b
b
b
b
b
b
Values are means (± SEM) of the two baseline periods ("baseline") and the two final test periods ("test"). Significant differences between test
and baseline are indicated in the "test" columns by a P < 0.05, and b P < 0.01. The right hand columns (A, B, and C) denote significant differences
between the tests: (A) changes during the time control versus changes during the insulin + KCI infusion study; (B) changes during insulin infusion
alone versus changes during the insulin + KCI infusion study; (C) changes during the time control study versus changes during the insulin + NaCI
infusion study. There were no significant differences between the changes during insulin alone and the changes during the insulin + NaCI infusion
study.
Abbreviations are: C, clearance; FE, fractional excretion.
Table 3. Plasma glucose, renin activity, and aldosterone, and blood pressure during each experiment
Time control Insulin Insulin ÷ KCI Insulin + NaCI
Baseline Test Baseline Test Baseline Test Baseline Test
Plasma glucose mmol/liter 4.3 0.1 4.2 0.2 4.5 0.2 4.2 0.2 4.3 0.1 4.4 0.3 4.0 0.3 4.1 0.3
Plasma renin activity fmol/!iter/sec 153 36 117 26 180 65 195 74 191 54 186 51 145 36 171 40
Plasma aldosterone pinol/liter 214 33 183 19 221 31 196 35 204 20 264 47 160 20 127 18
SystolicbloodpressuremmHg 125±3 127±4 124±3 128±3 124±3 126±2 127±1 129±3
Diastolic blood pressure mm Hg 72 2 70 2 73 2 71 2 74 1 70 2 70 2 67 2
Values are means (± SEM) of the baseline collection periods ("baseline") and of the two final test collection periods ("test").
a Significant differences between test and baseline, P < 0.05.
reabsorption somewhere beyond the proximal tubules. The
present data in humans accord well with this idea.
The decrease in minimal urine osmolality and increase in the
term [CH2J(CH20 + Cr1)] suggest that insulin stimulated sodium
reabsorption in the diluting segment. Kirchner [20] found no
effect of insulin on chloride reabsorption in micropuncture-
accessible proximal tubules. However, marked stimulation of
chloride reabsorption in Henle's loop appeared likely in view of
the decrease in early distal chloride delivery. Since early distal
fluid delivery was not decreased, it was suggested that insulin
increased chloride reabsorption in the thick ascending limb of
Henle's loop [20]. Thus, the presently observed fall in sodium
Friedberg et a!: Insulin and renal Na handling 255
and potassium excretion may reflect increased re-absorption in
Henle's loop.
Under the conditions of our study, the diluting segment also
comprises the nephron segments downstream from Henle's
loop [14, 15]. In this respect, it is relevant that Kirchner [20] did
not find an effect of insulin on chloride reabsorption in micro-
puncture-accessible distal convoluted tubules. Since insulin
enhances aldosterone-stimulated sodium reabsorption and po-
tassium secretion, and Na,K-ATPase activity in cultered
toad urinary bladder and toad kidney cells [11, 21], it is possible
that insulin increased sodium reabsorption in the collecting
tubules. However, the simultaneous decrease in potassium
excretion speaks against this option, since increased sodium
reabsorption at this site would favor potassium secretion [21,
22]. Instead, it seems likely that insulin impaired potassium
secretion in this segment by a combination of decreased sodium
delivery and peritubular potassium concentration, both impor-
tant determinants of potassium secretion in the collecting
tubules [22, 23].
Infusion of KCI fully prevented the fall in urine osmolality
and rise in diluting segment reabsorption caused by insulin, also
in agreement with the notion that hypokalemia plays a mediat-
ing role in the sodium retaining effect of insulin. In view of the
above considerations, increased sodium reabsorption in Hen-
le's loop during insulin infusion seems a conceivable option, but
we are not aware of any direct evidence that acute hypokalemia
increases NaCl reabsorption in this segment. However, that
this also is a conceivable option can be derived from the
opposite observation during acute hyperkalemia. Milanes and
Jamison [24] found increased early-distal sodium and potassium
delivery after a potassium load in partially nephrectomized rats,
although this effect did not exceed the effect of a corresponding
NaCI load. Kirchner found decreased chloride reabsorption in
Henle's loop after a potassium load in micropuncture-studied
rats [25]. Stokes [26] demonstrated in in-vivo microperfusion
experiments that an increase in peritubular potassium concen-
tration reduced NaCI reabsorption and changed potassium
reabsorption into secretion in medullary thick ascending limbs.
In view of these observations during acute hyperkalemia, it
seems not unreasonable to assume that acute hypokalemia
would increase the reabsorption of sodium, potassium, and
chloride in Henle's loop, nor that prevention of hypokalemia
would prevent this effect. An increase in peritubular potassium
concentration was shown to increase sodium reabsorption in
late distal tubule and the cortical collecting tubule in rodents
[23, 27]. This argues against these segments as sites where
hypokalemia might mediate the sodium retaining effect of
insulin.
Insulin infusion slightly increased lithium excretion. In-
creased lithium clearance together with sodium retention has
been found earlier during glucose infusion [28], a situation in
which insulin is also high. This finding confirms that insulin did
not increase sodium reabsorption in the proximal tubules.
However, although most lithium is undoubtedly reabsorbed in
the proximal tubules, there is evidence that some is reabsorbed
in Henle's loop [17, 29]. Even though this may not be much, one
would not expect a rise in lithium excretion if sodium reabsorp-
tion in Henle's loop is increased. Therefore, we cannot exclude
that insulin indeed increases sodium reabsorption somewhere
distal from Henle's loop. In any case, it is likely that the
increase in sodium reabsorption occurred independently of site
and mechanism of decreased lithium reabsorption, since so-
dium and lithium are supposed to be transported at least in the
same direction in those segents where both are handled [17].
Therefore, the finding that, by exception, KCI did not prevent
this effect of insulin, is not in disagreement with the idea that
KCI infusion interfered with the mechanism by which insulin
causes sodium retention.
In the time control study the PRA decreased, probably
reflecting diurnal rhythm. This was not seen during insulin
infusion, suggesting that insulin stimulates renin release, in
accordance with other recent data in humans by Trovati et al
[30]. The macula densa mechanism might be involved, assum-
ing that insulin indeed increases sodium reabsorption upstream.
In that case we would expect that KC1 would have prevented
the renin stimulation, which was not found. However, it should
be mentioned that KCI did prevent insulin-induced renin stim-
ulation in Trovati et al's study [30]. Whether this discrepancy
between the two studies concerns a methodological problem is
not apparent. That the potassium ion may be involved also in
this effect of insulin is suggested by the observation in experi-
mental animals that administration of potassium, independent
of the accompanying anion, suppresses plasma renin [31, 32]. In
neither of the present experiments significant were changes in
aldosterone found, despite important variations in plasma po-
tassium. Perhaps this is due to the high sodium intake in our
study, since potassium-related aldosterone variability is proba-
bly low at low levels of angiotensin II [33]. Anyway, it is
unlikely that aldosterone mediated the decrease in urinary
sodium and potassium excretion during insulin infusion, nor
prevented this change during the combined infusion.
Intrarenal insulin infusion has been shown to increase ipsi-
lateral sodium reabsorption [7], clearly in favor of direct medi-
ation of this effect. The presence of high concentrations of
insulin receptors in the kidney, in particular along the thick
ascending limbs of Henle's loop [34], is compatible with a direct
effect. However, many of these receptors may be involved with
insulin degradation instead of the mediation of transport effects
[35], and it is unknown whether a direct effect is indeed the
main mechanism by which insulin causes sodium retention in
vivo. Our data suggest a crucial role for hypokalemia: insulin
either increases sodium reabsorption through mediation of
hypokalemia, or exerts this effect directly provided that plasma
potassium is reduced. However, clearance techniques have
obvious limitations, and from the present studies in humans it is
impossible to exactly define the site of interaction of potassium
and insulin in the kidney, or even to make certain whether such
interaction exists. Also, we cannot discern whether the pro-
posed effect of potassium concerns a direct action of potassium
on tubule cells, or requires further intermediate steps, such as
changes in renal vascular tone. Animal studies will be needed to
resolve these questions.
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